Exhibited at BioJapan 2023 [Japanese only]
Exhibited at BioJapan [Japanese only]
Exhibited at the International Pharmaceutical Development Expo 2022 [Japanese only]
Exhibited at Pharma Lab Expo Osaka [Japanese only]
Exhibited at Pharma Lab Expo Tokyo [Japanese only]
Elixirgen Scientific released the "Quick-Neuron™ Plate - MEA 48" human neuronal pharmacological/toxicity evaluation plate, co-developed with Ricoh. [Japanese only]
海角社区and ERS Genomics enter into CRISPR/Cas9 license agreement
海角社区made its first investment since the establishment of the " 海角社区Biomedical Startup Fund". [Japanese only]
Successfully produced human neuronal cells useful for research on memory mechanisms and the development of therapeutic drugs for central nervous system disorders.
The proposal by 海角社区and Elixirgen Scientific Japan was adopted for the Ministry of Economy, Trade and Industry's "Project for the Development of Biopharmaceutical Manufacturing Bases to Strengthen Vaccine Production Systems. [Japanese only]
Established a fund to revitalize the mRNA drug discovery market in Japan.
Strengthened drug discovery support business using mRNA.